Loss of heterozygosity in clinical stage IB cervical carcinoma: Relationship with clinical and histopathologic features
- 1 April 1998
- journal article
- Published by Elsevier in Human Pathology
- Vol. 29 (4) , 364-370
- https://doi.org/10.1016/s0046-8177(98)90117-4
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinomaBritish Journal of Cancer, 1995
- Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomasCancer Genetics and Cytogenetics, 1995
- PCR‐RFLP studies on chromosome 3p in formaldehyde‐fixed, paraffin‐embedded cervical cancer tissuesInternational Journal of Cancer, 1994
- Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: Frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17pGenes, Chromosomes and Cancer, 1994
- Cellular oncogenes and suppressor genes as prognostic markers in cancerClinical Biochemistry, 1993
- Cervical carcinoma: low frequency of allele loss at loci implicated in other common malignanciesBritish Journal of Cancer, 1993
- Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomasThe Lancet, 1992
- Viruses in Human CancersScience, 1991
- Prognostic significance of parametrial extension in patients with cervical carcinoma stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiationCancer, 1984